Chronic TLR4 activation connects dysbiosis and intestinal permeability with atherosclerosis, insulin resistance, and neuroinflammation.
Omega-3s inhibit LPS binding to TLR4 and reduce its abundance in membranes: part of their cardioprotective effect works through this.
Circulating LPS activates TLR4 at the blood-brain barrier and triggers neuroinflammation that contributes to cognitive decline.
*⏱ 2 min read
Toll-like receptors are a family of pattern recognition receptors expressed on the surface of immune cells and other cells; they are the main inducers of innate immunity, activating transcription factors such as NF-kB that increase the expression of inflammatory cytokines; among the toll-like receptors, TLR4 is notable for recognizing lipopolysaccharide, a structure found in the outer membranes of gram-negative bacteria, and is the key protein linking intestinal permeability to systemic inflammation and aging.
Although the innate inflammatory response is necessary for normal immunity, chronic activation of toll-like receptors due to increased exposure to LPS driven by gut dysbiosis and intestinal permeability can contribute to the chronic low-grade inflammation that has been linked to multiple age-related diseases, including atherosclerosis, insulin resistance, neurodegenerative diseases, and cancer; this phenomenon of microbiome-induced chronic inflammation mediated by TLR4 is known as metabolic endotoxemia.
Metabolic endotoxemia, a condition in which bacterial LPS enters the bloodstream at chronically elevated levels, has been proposed as a unifying mechanism linking the Western diet to obesity, type 2 diabetes, cardiovascular disease, and neuroinflammation; circulating LPS activates TLR4 on immune cells and on cells of the blood-brain barrier, which can trigger neurological inflammation and contribute to age-related cognitive decline through the same TLR4/NF-kB mechanism that operates in the periphery.
Omega-3 fatty acids reduce TLR4 activation through multiple mechanisms: they directly inhibit the binding of LPS to TLR4; they reduce the abundance of TLR4 on cell membranes; they generate specialized pro-resolving mediators that actively silence inflammation; and they favor butyrate-producing gut bacteria that strengthen the intestinal barrier, reducing the bacterial translocation and metabolic endotoxemia that activate TLR4 in the first place; this is one of the reasons omega-3 fatty acids have such broad cardiovascular and neurological effects.
Information, not medical advice. Scientific evidence reflects the quality of the studies.